首页> 美国卫生研究院文献>Molecules >Design Synthesis and Biological Evaluation of New Antioxidant and Neuroprotective Multitarget Directed Ligands Able to Block Calcium Channels
【2h】

Design Synthesis and Biological Evaluation of New Antioxidant and Neuroprotective Multitarget Directed Ligands Able to Block Calcium Channels

机译:能够阻断钙通道的新型抗氧化和神经保护多靶标定向配体的设计合成和生物学评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We report herein the design, synthesis and biological evaluation of new antioxidant and neuroprotective multitarget directed ligands (MTDLs) able to block Ca channels. New dialkyl 2,6-dimethyl-4-(4-(prop-2-yn-1-yloxy)phenyl)-1,4-dihydropyridine-3,5-dicarboxylate MTDLs – , resulting from the juxtaposition of nimodipine, a Ca channel antagonist, and rasagiline, a known MAO inhibitor, have been obtained from appropriate and commercially available precursors using a Hantzsch reaction. Pertinent biological analysis has prompted us to identify the MTDL 3,5-dimethyl-2,6–dimethyl–4-[4-(prop–2–yn–1-yloxy)phenyl]-1,4-dihydro- pyridine- 3,5-dicarboxylate ( ), as an attractive antioxidant (1.75 TE), Ca channel antagonist (46.95% at 10 μM), showing significant neuroprotection (38%) against H O at 10 μM, being considered thus a hit-compound for further investigation in our search for anti-Alzheimer’s disease agents.
机译:我们在此报告了能够阻断Ca通道的新型抗氧化剂和神经保护性多靶标定向配体(MTDLs)的设计,合成和生物学评估。新的2,6-二甲基-4-(4-(4-(丙-2-炔-1-基氧基)苯基)二烷基)-1,4-二氢吡啶-3,5-二羧酸MTDLs –是由于尼莫地平(Ca)通道拮抗剂和雷沙吉兰(一种已知的MAO抑制剂)已使用Hantzsch反应从合适的市售前体中获得。相关的生物学分析促使我们鉴定出MTDL 3,5-二甲基-2,6-二甲基-2-4- [4-(丙-2-基-yn-1-基氧基)苯基] -1,4-二氢吡啶-3 ,5-二羧酸盐(),作为一种有吸引力的抗氧化剂(1.75 TE),Ca通道拮抗剂(在10μM时为46.95%),对10μM的HO具有显着的神经保护作用(38%),因​​此被认为是一种有待进一步研究的命中化合物在我们寻找抗阿尔茨海默氏病的药物中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号